Giles Gwinnett is a qualified journalist and has been a reporter for a number of regional newspapers and for a press agency. He was formerly a news analyst on the German team at Thomson Financial, now Thomson Reuters. He has a bachelor’s degree in English Literature and German and a master's in Film Studies.
Dr Bath has broad experience in vaccine and therapeutic design, development and testing, the firm said
Watt has already played a significant role in the growth of the company
It was possible to collect, process, gather and ship the blood test from all five participating hospitals within 24 hours.
The global market for pain management drugs exceeded $62 billion in 2016...
The firm aims to secure CE Mark for the screening test by the end of the third quarter 2018
Revenues for the firm's products and services increased 21% in the third quarter alone
LeanLife has developed a patented process to isolate omega 3 fatty acids from flax (linen) seeds
Analyst Raghuram Selvaraju repeated a 'buy' stance and targets A$1.50 for the shares
Analyst Craig Stanley, back from a site visit, repeated a 'buy' on the stock
The Tiple Block acreage is adjacent to Geopark’s prolific Llanos 34 Block
A look at some of the analyst comment on North America listed stocks on Monday
A look at some analyst views from around the City on Friday